The DOI matches its Crossref record; 242 of the 243 references it cites were found in a registry or an index.
Mitochondrial Dysfunction and Synaptic Transmission Failure in Alzheimer’s Disease
Open accessAbstract
Alzheimer’s disease (AD) is a chronic neurodegenerative disorder, in which multiple risk factors converge. Despite the complexity of the etiology of the disease, synaptic failure is the pathological basis of cognitive impairment, the cardinal sign of AD. Decreased synaptic density, compromised synaptic transmission, and defected synaptic plasticity are hallmark synaptic pathologies accompanying AD. However, the mechanisms by which synapses are injured in AD-related conditions have not been fully elucidated. Mitochondria are a critical organelle in neurons. The pivotal role of mitochondria in supporting synaptic function and the concomitant occurrence of mitochondrial dysfunction with synaptic stress in postmortem AD brains as well as AD animal models seem to lend the credibility to the hypothesis that mitochondrial defects underlie synaptic failure in AD. This concept is further strengthened by the protective effect of mitochondrial medicine on synaptic function against the toxicity of amyloid-β, a key player in the pathogenesis of AD. In this review, we focus on the association between mitochondrial dysfunction and synaptic transmission deficits in AD. Impaired mitochondrial energy production, deregulated mitochondrial calcium handling, excess mitochondrial reactive oxygen species generation and release play a crucial role in mediating synaptic transmission deregulation in AD. The understanding of the role of mitochondrial dysfunction in synaptic stress may lead to novel therapeutic strategies for the treatment of AD through the protection of synaptic transmission by targeting to mitochondrial deficits.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Apart from this, Aβ induces hypersensitivity of NMDA receptors and also disrupts the regulatory control of NMDA activity causing excitotoxicity [12].”
From Recent Advancements in Pathogenesis, Diagnostics and Treatment of Alzheimer’s Disease (2020) · cites this paper as [12]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Mitochondrial Dysfunction and Oxidative Stress in Neurodegenerative Diseases
Lin, M. T., & Beal, M. F. (2006) · Nature · doi:10.1038/nature05292 · Cited by 6,455
Control of inositol 1,4,5-trisphosphate-induced Ca2+ release by cytosolic Ca2+
Bootman, M. D., Missiaen, L., Parys, J. B., SMEDT, H. D., & Casteels, R. (1995) · Biochemical Journal · doi:10.1042/bj3060445 · Cited by 5,131
Querfurth, H. W., & LaFerla, F. M. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0909142 · Cited by 4,569
Alzheimer's Disease Is a Synaptic Failure
Selkoe, D. J. (2002) · Science · doi:10.1126/science.1074069 · Cited by 4,420
Terry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397
Triple-Transgenic Model of Alzheimer’s Disease with Plaques and Tangles
Oddo, S., Caccamo, A., Shepherd, J. D., Murphy, M. P., Golde, T. E., Kayed, R., Metherate, R., Mattson, M. P., Akbari, Y., & LaFerla, F. M. (2003) · Neuron · doi:10.1016/s0896-6273(03)00434-3 · Cited by 4,126
Interplay between Cortical Spreading Depolarization and Seizures
Kramer, D. R., Fujii, T., Ohiorhenuan, I. E., & Liu, C. Y. (2017) · Stereotactic and Functional Neurosurgery · doi:10.1159/000452841 · Cited by 3,721
An Energy Budget for Signaling in the Grey Matter of the Brain
Attwell, D., & Laughlin, S. B. (2001) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200110000-00001 · Cited by 3,543
Seth, R. B., Sun, L., Ea, C.-K., & Chen, Z. J. (2005) · Cell · doi:10.1016/j.cell.2005.08.012 · Cited by 3,329
Flagged first, then by citations
1 of the 243 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- 10.1007/s007020050073 · DOI
Cited by
Sorted by citations
Items 201–211 of 211
Yang, M., Shen, Y., Zhao, S., Zhang, R., Dong, W., & Lei, X. (2023) · Figshare · doi:10.6084/m9.figshare.22697034
MITOCHONDRIAL DYSFUNCTION IN DISEASE: PATHOGENIC MECHANISMS AND NOVEL THERAPIES
Wycik, M., Chmielewski, H., Komar, J., Wądołowski, A., Kondratiuk, G., Kondrat, A., Szczupak, M., Mierzejewski, P., Werno, J., & Twarowska, Z. (2025) · International Journal of Innovative Technologies in Social Science · doi:10.31435/ijitss.4(48).2025.4424
Neuronal and glial networks interact with traumatic brain injury to modulate cognition in ABCD study
Cheng, M., Mao, M., Meng, W., Jacobus, J., Troyer, E. A., Delfel, E. L., Dennis, E. L., Wilde, E. A., Abildskov, T. J., de Souza, N. L., et al. (2026) · npj Systems Biology and Applications · doi:10.1038/s41540-026-00681-8
Neuronal mitochondrial dynamics: roles in brain disorders and therapeutic potential
Zhang, X., Du, J., Wang, S.-Z., Mo, X., & Zhang, X. (2026) · Acta Pharmacologica Sinica · doi:10.1038/s41401-025-01746-w · Cited by 3
Metabolic reprogramming of neurons in alzheimer disease: a biochemical perspective
Farzeen, I., BATOOL, M., Saeed, S., Mustafa, G., YASMEEN, M., Nazir, M. M., & Ashraf, A. (2026) · Metabolic Brain Disease · doi:10.1007/s11011-026-01838-4 · Cited by 1
Khodadadi, S., Rezaeimanesh, N., Motahar, A. A., Yousefi, F., Avateffazeli, M., Montazeri‐Shatouri, R., Hosseini, E., Negah, S. S., & Moghadasi, A. N. (2026) · International review of neurobiology · doi:10.1016/bs.irn.2026.06.001
Biochemical modulators of synaptic plasticity: New horizons in Alzheimer's disease treatment
Farzeen, I., Nazir, M. M., Jaan, Z., Ghaffar, W., Masood, A., YASMEEN, M., Ashraf, A., & Różański, H. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261469864
Mitochondrial molecular diversity in the brain
Sainz, A. G., & Wang, X. (2026) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2026.103270
Salman, T., Luo, Z., Johnson, D. E., Noorani, A. A., Wan, Z., Bordieanu, B., Ye, Z., Penrod, R. D., Xian, H., Fitting, S., et al. (2026) · Advanced Science · doi:10.1002/advs.78144
Matei, C., Palade, N. A., Dobri, A.-M., Dumitriu, D. O., Mutu, C., Popescu, A., Pintea, A. L., & Atasie, D. (2026) · Life · doi:10.3390/life16101749
Malhotra, A., Rao, G. M., Marathe, A., Rai, S., Rani, V. S., Patil, A., Upadhya, D., & Chakrapani, M. (2026) · Oxidative Medicine and Cellular Longevity · doi:10.1155/omcl/5350976
Metadata
- Authors
- Guo, L., Tian, J., & Du, H.
- Affiliations
- The University of Texas at Dallas (US)
- Shandong University (CN)
- Corresponding author
- Du, Heng
- Venue
- Journal of Alzheimer’s Disease
- Publisher
- SAGE Publications
- Published
- 2016-09-20
- Volume
- 57
- Issue
- 4
- Pages
- 1071-1086
- ISSN
- 1387-2877 (ISSN-L)
- 1875-8908
- PMC
- PMC5605817
- OpenAlex
- W2522744939
- Cited by
- 211
- References
- 243
- Citations by year
- 2026: 26 · 2025: 31 · 2024: 29 · 2023: 31 · 2022: 22 · 2021: 22 · 2020: 28 · 2019: 17 · 2018: 3 · 2017: 2
- FWCI
- 0.86
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Alzheimer s Disease (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute on Aging (R00AG037716, R01AG053588)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- Alzheimer's disease, mitochondrial dysfunction
- MeSH terms
- Alzheimer Disease, Animals, Humans, Mitochondria, Synaptic Transmission, Mitochondrial Diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
